Ahmed Ali

Dr. Ahmed Ali

Aesthetic and restorative Dentistry Department, College of Dentistry, University of Baghdad
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2018 in Journal of Dental Research
Verified
Journal Article
Open access
AAAhmed Ali
Ahmed Ali
GKG. Koller
G. Koller
Federico FoschiFederico Foschi
Federico Foschi
MAM. Andiappan
M. Andiappan
KBK.D. Bruce
K.D. Bruce
FMFrancesco Mannocci
Francesco Mannocci
A single-blind randomized controlled clinical trial in patients with deep caries and symptoms of reversible pulpitis compared outcomes from a self-limiting excavation protocol using chemomechanical Carisolv gel/operating microscope (self-limiting) versus selective removal to leathery dentin using rotary burs (control). This was followed by pulp protection with mineral trioxide aggregate (MTA) and restoration with glass ionomer cement and resin composite, all in a single visit. The pulp sensibility and periapical health of teeth were assessed after 12 mo, in addition to the differences in bacterial tissue concentration postexcavation. Apical radiolucencies were assessed using cone beam computed tomography/periapical radiographs (CBCT/PAs) taken at baseline 0 mo (M0) and 12 mo (M12). In total, 101 restorations in 86 patients were placed and paired subsurface, and deep (postexcavation) dentin samples were obtained. DNA was extracted and bacteria-specific 16S ribosomal RNA gene quantitative polymerase chain reaction was performed. No significant difference was found in bacterial copy numbers normalized to mass of dentin (“bacterial tissue concentration”) between the self-limiting (96.3% reduction) and control protocols (97.1%, P = 0.33). The probability of 12-mo success was 4 times (odds ratio [OR] = 4.33; confidence interval [CI], 1.2–15.6; P = 0.025) higher in the self-limiting protocol compared to the control (conventional excavation technique), with pulp survival rates of 73.3% and 90%, respectively (P = 0.049). Molars had a 4 times higher probability of success compared to premolars (OR, 4.17; CI, 1.17–14.9; P = 0.028), and symptom severity did not statistically predict outcome (OR, 0.41; CI, 0.12–13.9, P = 0.153). CBCT detected significantly more periapical (PA) lesions than PA radiographs at the baseline visit (P < 0.001). In conclusion, the self-limiting caries excavation protocol under magnification increased pulp survival rate compared to rotary bur excavation (ClinicalTrials.gov NCT03071588).


29 November 2024 in Journal of Endodontics
Verified
Journal Article
Closed access
HIHaider A. Ibrahim
Haider A. Ibrahim
AAAhmed Ali
Ahmed Ali
FMFrancesco Mannocci
Francesco Mannocci

26 July 2019 in Dental Materials Journal
Verified
Journal Article
Closed access
PDF file
AAAhmed Almaroof
Ahmed Almaroof
AAAhmed Ali
Ahmed Ali
FMFrancesco Mannocci
Francesco Mannocci
SDSanjukta Deb
Sanjukta Deb
This study evaluates the reinforcement of semi-interpenetrating network composites of 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropyl)phenyl] propane (Bis-GMA)/ triethyleneglycol dimethacrylate (TEGDMA)/polymethyl methacrylate (PMMA) and 25% titanium dioxide (TiO2) nanofiller with surface treated Kevlar fibers for potential application as dental posts. The post material was subjected to thermo-cycling and flexural strength determined, characterised by dynamic mechanical analysis, water sorption, radiopacity and cytotoxicity tests. The results were compared with everStick®POST. Kevlar pre-treatment with acetic acid and silane coupling agent demonstrated a clear effect on the flexural strength of the composites with a significant increase compared to composites with fibers without surface treatment. The inclusion of TiO2 into the final formulation provided the desired radiopacity and improved both aesthetics and flexural strength, which exhibits a higher resistance on thermocycling. The ratios of fatigue limit to static flexural strength were about 0.73 for Kevlar and 0.58 for everStick®POST; MTT assay confirmed the absence of any toxic eluents, indicating its feasibility as new intracanal post material.

1 June 2018 in World Journal of Dentistry
Verified
Journal Article
Open access
AAAhmed Ali
Ahmed Ali
AAAhmed Almaroof
Ahmed Almaroof
FFFrederic Festy
Frederic Festy
ABAvijit Banerjee
Avijit Banerjee
FMFrancesco Mannocci
Francesco Mannocci

25 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AAAhmed Ali
Ahmed Ali
FTFarah Ben Thani
Farah Ben Thani
Federico FoschiFederico Foschi
Federico Foschi
ABAvijit Banerjee
Avijit Banerjee
FMFrancesco Mannocci
Francesco Mannocci
Background: the aim of this study was to assess the 2-year pulp survival of deep carious lesions in teeth excavated using a self-limiting protocol in a single-blind randomized controlled clinical trial. Methods: At baseline, 101 teeth with deep carious lesions in 86 patients were excavated randomly using self-limiting or control protocols. Standardized clinical examination and periapical radiographs of teeth were performed after 1- and 2-year follow-ups (REC 14/LO/0880). Results: During the 2-year period of the study, 24 teeth failed (16 and 8 at T12 and T24, respectively). Final analysis shows that 39/63 (61.9%) of teeth were deemed successful (16/33 (48.4%) and 23/30 (76.6%) in the control and experimental groups, respectively with a statistically significant difference (z score = 2.3, p = 0.021). Of teeth with severe and mild symptoms at T0, 42.9% and 36.7% respectively failed at T24 (p > 0.05). Within the self-limiting group, there was a lower success in premolars compared to molars (p < 0.05). Conclusion: after 2 years, there was a statistically significant higher pulp survival rate of teeth with deep carious lesions excavated using self-limiting protocols in patients with reversible pulpitis. Molars showed higher success than premolars in teeth excavated using the self-limiting protocol. There was no statistically significant association between the outcome and the severity of symptoms at T0 (ClinicalTrials.gov NCT03071588).